Evidence map›Paper›PMID 37700830›Full record

ArticleFrontiers in oncology2023

Intravitreal methotrexate in type B lymphoblastic leukemia-Case Report.

Maria Isabel Maya Naranjo, Sebastián Vallejo López, Sara Mesa Mesa, Mónica Ortiz Pérez, Mariana López Posada, Martha Lía Gaviria Bravo, María Elena González Alviar

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Maria Isabel Maya NaranjoDepartment of Ophthalmology, Universidad Pontificia Bolivariana, Medellín, Colombia.
Sebastián Vallejo LópezDepartment of Ophthalmology, Universidad de Antioquia, Medellín, Colombia.
Sara Mesa MesaDepartment of Ophthalmology, Universidad Pontificia Bolivariana, Medellín, Colombia.
Mónica Ortiz PérezDepartment of Ophthalmology, Universidad Pontificia Bolivariana, Medellín, Colombia.
Mariana López PosadaDepartment of Ophthalmology, Universidad de Antioquia, Medellín, Colombia.
Martha Lía Gaviria BravoDepartment of Ophthalmology, Universidad de Antioquia, Medellín, Colombia.
María Elena González AlviarDepartment of Ophthalmology, Universidad de Antioquia, Medellín, Colombia.
Universidad de Antioquia · COUniversidad Pontificia Bolivariana · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leukemia is a common neoplasia that, in its progress, can have ocular involvement due to direct infiltration or secondary to hematological alterations typical of the disease. These findings are consistent with an involvement of the central nervous system and are thus related to the prognosis. Despite the existing systemic therapies, there needs to be more literature that shows the treatment in the ocular involvement of this disease. A case report of a child with ocular involvement due to treatment-refractory acute lymphoblastic leukemia, successfully managed with intravitreal methotrexate, is presented.

Indexed as

acute lymphoblastic leukemiacase reporthypopionintravitreal injectionmethotrexate

Identifiers

PMID37700830
PMCPMC10493324
OpenAlexW4386236547

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.